Annual ROE
-49.83%
-31.55%-172.59%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual return on equity is currently -49.83%, with the most recent change of -31.55% (-172.59%) on 31 December 2023. During the last 3 years, it has fallen by -112.90% (-179.01%). ACRV annual ROE is now -173.04% below its all-time high of 68.22%, reached on 31 December 2021.ACRV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-47.95%
-0.64%-1.35%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly return on equity is currently -47.95%, with the most recent change of -0.64% (-1.35%) on 30 September 2024. Over the past year, it has dropped by -15.56% (-48.04%). ACRV quarterly ROE is now -163.74% below its all-time high of 75.23%, reached on 30 September 2022.ACRV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -172.6% | -48.0% |
| 3 y3 years | -179.0% | -268.3% |
| 5 y5 years | - | - |
ACRV ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -173.0% | at low | -163.7% | +54.7% |
| 5 y | 5 years | -173.0% | at low | -163.7% | +54.7% |
| alltime | all time | -173.0% | at low | -163.7% | +54.7% |
Acrivon Therapeutics Common Stock ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -47.95%(+1.4%) |
| June 2024 | - | -47.31%(-4.7%) |
| Mar 2024 | - | -49.66%(+17.0%) |
| Dec 2023 | -49.83%(+172.6%) | -42.45%(+31.1%) |
| Sept 2023 | - | -32.39%(-21.5%) |
| June 2023 | - | -41.24%(-30.1%) |
| Mar 2023 | - | -59.02%(-44.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -18.28%(-126.8%) | -105.91%(-240.8%) |
| Sept 2022 | - | 75.23%(+14.6%) |
| June 2022 | - | 65.66%(+11.6%) |
| Mar 2022 | - | 58.81%(+106.4%) |
| Dec 2021 | 68.22%(+8.2%) | - |
| Dec 2021 | - | 28.49% |
| Dec 2020 | 63.07% | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual return on equity?
- What is the all time high annual ROE for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual ROE year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly return on equity?
- What is the all time high quarterly ROE for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly ROE year-on-year change?
What is Acrivon Therapeutics Common Stock annual return on equity?
The current annual ROE of ACRV is -49.83%
What is the all time high annual ROE for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual return on equity is 68.22%
What is Acrivon Therapeutics Common Stock annual ROE year-on-year change?
Over the past year, ACRV annual return on equity has changed by -31.55% (-172.59%)
What is Acrivon Therapeutics Common Stock quarterly return on equity?
The current quarterly ROE of ACRV is -47.95%
What is the all time high quarterly ROE for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly return on equity is 75.23%
What is Acrivon Therapeutics Common Stock quarterly ROE year-on-year change?
Over the past year, ACRV quarterly return on equity has changed by -15.56% (-48.04%)